Heparin II domain of fibronectin mediates contractility through an alpha4beta1 co-signaling pathway.
Schwinn
Marie K
MK
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53706, USA.
Gonzalez
Jose M
JM
Gabelt
B'Ann T
BT
Sheibani
Nader
N
Kaufman
Paul L
PL
Peters
Donna M
DM
D000199:Actins / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002448:Cell Adhesion; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism*; D003599:Cytoskeleton / Q000378:metabolism; D015536:Down-Regulation; D005353:Fibronectins / Q000378:metabolism*; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D039041:Integrin alpha4beta1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D007429:Intraocular Pressure; D008253:Macaca mulatta; D008297:Male; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014129:Trabecular Meshwork / Q000166:cytology / Q000378:metabolism*
D000199:Actins; D005353:Fibronectins; D039041:Integrin alpha4beta1; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D006493:Heparin; D003094:Collagen